Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding

Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma

NCT06644430 ·Status: RECRUITING

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

NCT04319484 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

NCT06365034 ·Status: RECRUITING

Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

NCT01137084 ·Status: COMPLETED ·Phase: NA

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

NCT02509169 ·Status: UNKNOWN ·Phase: PHASE2

Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma

NCT05701553 ·Status: RECRUITING

Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

NCT03672305 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

NCT04053985 ·Status: UNKNOWN ·Phase: PHASE3

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

NCT05056337 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

NCT05352204 ·Status: COMPLETED

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

NCT04611373 ·Status: UNKNOWN ·Phase: PHASE3

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

NCT06622031 ·Status: RECRUITING ·Phase: NA

The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene

NCT01786980 ·Status: COMPLETED

Liver Cancer Prognosis Investigation Study

NCT06623734 ·Status: NOT_YET_RECRUITING

Lenvatinib Therapy in HCC Patients After LDLT

NCT05572528 ·Status: RECRUITING

A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

NCT02686372 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC

NCT04241523 ·Status: UNKNOWN ·Phase: PHASE2

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)

NCT05750329 ·Status: NOT_YET_RECRUITING ·Phase: NA

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

NCT05609695 ·Status: UNKNOWN

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

NCT00501813 ·Status: UNKNOWN ·Phase: PHASE3

A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

NCT02719782 ·Status: UNKNOWN ·Phase: PHASE1

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

NCT04168944 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma

NCT00556803 ·Status: UNKNOWN ·Phase: PHASE4

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

NCT06643533 ·Status: NOT_YET_RECRUITING

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

NCT04627012 ·Status: COMPLETED